RESHAPE LIFESCIENCES INC (RSLS) Stock Balance Sheet
NASDAQ:RSLS - Nasdaq - US76090R3093 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 2.52M | 693.00K | 4.46M | 3.86M | 22.77M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 761.00K | 1.03M | 1.66M | 2.18M | 2.82M | |||
| Inventories | 2.53M | 2.46M | 3.74M | 3.61M | 3.00M | |||
| Other Current Assets | 487.00K | 407.00K | 437.00K | 260.00K | 1.36M | |||
| Total Current Assets | 6.29M | 4.59M | 10.30M | 9.91M | 29.94M | |||
| Non-Current Assets | ||||||||
| PPE Net | 133.00K | 154.00K | 310.00K | 870.00K | 1.72M | |||
| Intangibles | N/A | N/A | 0.00 | 260.00K | 20.83M | |||
| Other Non-Current Assets | 55.00K | 51.00K | 57.00K | 100.00K | 50.00K | |||
| Total Non-Current Assets | 188.00K | 205.00K | 367.00K | 1.23M | 22.59M | |||
| TOTAL ASSETS | 6.48M | 4.79M | 10.66M | 11.14M | 52.53M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 811.00K | N/A | N/A | 0.00 | |||
| Accrued Expenses | 1.18M | 1.01M | 1.17M | 4.09M | 2.59M | |||
| Accounts Payable | 1.69M | 2.21M | 1.69M | 1.93M | 3.47M | |||
| Other Current Liabilities | 1.26M | 957.00K | 921.00K | 1.46M | 1.48M | |||
| Total Current Liabilities | 4.12M | 4.99M | 3.78M | 7.48M | 7.53M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | 0.00 | 370.00K | |||
| Other Non-Current Liabilities | 1.13M | 61.00K | 223.00K | 0.00 | 300.00K | |||
| Total Non-Current Liabilities | 1.13M | 61.00K | 223.00K | 0.00 | 670.00K | |||
| TOTAL LIABILITIES | 5.25M | 5.05M | 4.00M | 7.48M | 8.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -641.23M | -642.70M | -635.57M | -624.19M | -577.97M | |||
| Additional Paid In Capital | 642.57M | 642.55M | 642.30M | 627.94M | 622.40M | |||
| Common Shares | 100.00 | 700.00 | 23.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -110.10K | -104.70K | -88.00K | -90.00K | -90.00K | |||
| Shares Outstanding | 133.10K | 29.20K | 16.20K | 400.00 | 300.00 | |||
| Tangible Book Value per Share | 9.24 | -8.66 | 411.80 | 9.44K | 94.00K | |||
| Total Shareholders' Equity | 1.23M | -253.00K | 6.66M | 3.66M | 44.33M | |||
| TOTAL LIABILITIES AND EQUITY | 6.48M | 4.79M | 10.66M | 11.14M | 52.53M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 1.53 | 0.92 | 2.73 | 1.32 | 3.98 | |||
| Return On Assets (ROA) | -53.42% | -148.76% | -106.79% | -414.81% | -120.22% | |||
| Return On Equity (ROE) | -281.54% | N/A | -170.90% | -1262.57% | -142.45% | |||
All data in USD , ROIC based on taxRate of 0.21